Tadalafil 20 - Pharmaceutical Grade

Tadalafil’s journey began in 1993 as IC351, a PDE5 inhibitor developed by ICOS Corporation. Its extended half-life—around 17.5 hours—set it apart from sildenafil, allowing for a 36-hour window of effectiveness. After partnering with Eli Lilly, the drug was branded Cialis and approved in 2003. Its success transformed ED treatment by offering not just efficacy, but also flexibility and improved patient satisfaction. Later approved for daily use, tadalafil became a symbol of innovation in sexual health, offering a discreet, long-acting alternative for men with erectile dysfunction.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tadalafil 20 by Pharmaceutical Grade, consult with your doctor or healthcare professional.